PreludeDx

PreludeDx delivers actionable tools to manage early stage breast cancer for patients and their physi

06/11/2026

Coming Soon: Game Changers with Hannah Storm, DCIS Survivor

Recorded at ASBrS 2026, this exciting new video series brings together leading breast cancer experts for important conversations on the challenges and opportunities in DCIS care.

Across 13 interviews, Sportscaster and DCIS survivor Hannah Storm explores topics including shared decision-making, radiation therapy considerations, personalized risk assessment, and how DCISionRT is helping support more individualized treatment decisions.

Over the coming weeks, we'll be sharing these conversations, each offering a unique perspective on DCIS and the future of breast cancer care.

Stay tuned for the full series!

06/04/2026

Looking for a doctor who offers DCISionRT but not sure where to start? We’d love to help.

There’s a map on our website that shows where physicians are who order the test. Once you find a location near you, click on the link, fill out the form and we’ll help you connect.

Just click here! https://bit.ly/4jYoDKh

05/29/2026

"I don't know why every doctor wouldn't order DCISionRT. Just order the test." — Holly, DCIS survivor

Holly was diagnosed with DCIS in early 2026 after her primary care physician put her on an enhanced screening protocol because of her family history. It took a conversation with a friend to find out about DCISionRT.

Her score was 0.8, the lowest possible, indicating that she wouldn't benefit from radiation treatment, and echoing the recommendations of both her surgeon and radiation oncologist.

Holly shared her full DCIS story with us a few days after receiving her result.

👉 Read Holly's full story here: https://bit.ly/4tXaMYJ

Thank you, Holly, for sharing your DCIS story with us.

05/19/2026

A major takeaway from ASBrS 2026: precision medicine is reshaping breast cancer care by helping clinicians personalize treatment decisions and reduce overtreatment.

Our larger-than-life DCISionRT® banner featuring Dr. Patrick Borgen’s statement — “Overtreatment of DCIS is real.” — sparked meaningful conversations throughout the meeting around genomics, biologic risk assessment, and de-escalation strategies.

Sessions from leading experts and KOLs reinforced the importance of individualized risk assessment in guiding DCIS care decisions.

PreludeDx is proud to help clinicians take the guesswork out of DCIS treatment planning.

05/11/2026

A powerful day at ASBrS with Hannah Storm and leading breast cancer experts discussing DCIS treatment, the importance of empowering patients with information, and reducing the fear and anxiety that can come with a diagnosis.

05/08/2026

What an incredible week in Seattle at the American Society of Breast Surgeons Annual Meeting 2026!

On behalf of the entire PreludeDx team, thank you to everyone who connected with us throughout the meeting — from our booth appearances with Hannah Storm, to conversations about AidaBREAST® and DCISionRT®, to our Grunge Fest event and every coffee, dinner, and hallway discussion in between.

We left inspired by the thoughtful conversations around genomics, biologic risk assessment, de-escalation strategies, and the growing impact of precision medicine in breast cancer care.

Together, we are helping shape a future where every patient benefits from more personalized treatment and care. Thank you for being part of the journey. 💙

05/05/2026

What a great few days at the ASBrS Annual Meeting in Seattle!

Thank you to everyone who stopped by, met with our team, and shared thoughtful insights throughout the meeting. We were energized by meaningful conversations with surgeons around DCISionRT®, AidaBreast® for early-stage invasive breast cancer, and the continued shift toward more personalized, biology-driven care.

One of the standout moments was Game Changers with Hannah Storm—bringing together top breast surgeons for important conversations on DCIS care and how we can better support more informed treatment decisions for patients.

We’re grateful for the engagement, collaboration, and continued commitment to advancing evidence-driven care. We look forward to keeping the conversation going beyond ASBrS!

04/30/2026

Hannah Storm is partnering with PreludeDx to host Game Changers, a series of discussions focused on DCIS and how treatment decisions are evolving.

As a DCIS patient herself who was able to safely omit radiation because of the DCISionRT test, her message is both personal and impactful.

If you’re attending the American Society of Breast Surgeons Annual Meeting in Seattle, stop by Booth 405 on Friday—and be sure to check out her IG Story for highlights.

04/27/2026

What a week!

PreludeDx’s Lab Week was packed with themed days, great energy, and even better company. From start to finish, it was a celebration of our team and the work we love.

A big THANK YOU to our partners who kept us well-fed with amazing breakfasts, lunches, and treats all week long:
Roche, Biocare, Quanterix, Millennium Systems, Twist, Cell Signaling, and Leica

We appreciate your support more than you know!

04/21/2026

“Stage zero doesn’t mean zero challenges.”

In a powerful new article published in Flow Space, Jennifer A Douglas - Author + DCIS Patient Advocate shares 5 things she wishes she had known before her DCIS diagnosis—and her perspective is one many patients will recognize.

From realizing that diagnosis is just the beginning, to navigating unexpected tests, difficult decisions, and a recovery that doesn’t end when treatment does, her story highlights the reality behind a condition often misunderstood as “early” or “simple.”

She also speaks to something critical: patients have a voice—and increasingly, access to tools that can help inform more personalized treatment decisions, including DCISionRT.

Stories like Jennifer’s are an important reminder that better outcomes start with better understanding.
Read her full story: https://bit.ly/4sTwegR

To learn more about Jennifer and her work supporting women through DCIS and beyond, visit her website: https://jenniferadouglas.com/

Address

26051 Merit Circle Suite 103
Laguna Hills, CA
92653

Website

http://www.preludedx.com/

Alerts

Be the first to know and let us send you an email when PreludeDx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to PreludeDx:

Shortcuts

Want your business to be the top-listed Engineering Company in Laguna Hills?